Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Nigeria destroys 1 million donated AstraZeneca vaccines with short shelf life

Published 23/12/2021, 07:56
Updated 23/12/2021, 07:57
© Reuters

By Camillus Eboh

ABUJA (Reuters) - Nigeria on Wednesday destroyed more than a million doses of expired AstraZeneca (NASDAQ:AZN) vaccines in a bid to assure a wary public that they have been taken out of circulation.

The destruction came more than a week after health authorities said some COVID-19 doses donated by rich Western nations had a shelf life that left only weeks to administer the shots. Reuters reported on Dec. 7 that around one million COVID-19 vaccines were estimated to have expired in Nigeria in November without being used.

At a dump site in Abuja, a bulldozer crushed AstraZeneca shots that were packed in cardboard boxes and plastic as reporters and health officials watched.

Faisal Shuaib, the National Primary Health Care Development Agency executive director told reporters that a shortage of vaccine supplies on the continent, had forced Nigeria to take the doses, knowing fully well they had a short shelf life.

"We have successfully withdrawn 1,066,214 doses of expired AstraZeneca vaccines. We have kept our promise to be transparent to Nigerians. The destruction today is an opportunity for Nigerians to have faith in our vaccination programme," Shuaib said.

Governments on the continent of over one billion people have been pushing for more vaccine deliveries as inoculation rates lag richer regions. The lower vaccination levels raise the risk of higher infection and death rates from COVID-19, especially as new, fast-spreading variants emerge such as Omicron.

Health minister Osagie Ehanire has said Nigeria will no longer accept vaccines with a short shelf life, citing a presidential committee decision.

The World Health Organisation said 12,971,729 vaccine doses have been administered in Nigeria as of Dec. 19.

Africa's most populous country, with a population exceeding 200 million, has recorded 227,378 COVID-19 cases and 2,989 deaths since the pandemic started.

Health experts say Nigeria needs to triple its vaccination drive from just over 100,000 doses a day to meet its target to inoculate more than half its population by the end of next year.

Recently, like many other African countries, Nigeria has seen a surge in vaccine supply, which has highlighted other issues relating to distribution and hesitation by citizens to get inoculated.

 

(Writing by MacDonald Dzirutwe; Editing by Bernadette Baum)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.